Europe — EMA
Gruzyqal (Amoxicillin Trihydrate, Potassium Clavulanate)
Learn about Gruzyqal, an EU prescription oral antibiotic containing amoxicillin trihydrate and potassium clavulanate, its uses, side effects, precautions, and interactions.
Request sourcing
What is Amoxicillin Trihydrate, Potassium Clavulanate?
Gruzyqal is an oral prescription medication marketed in the European Union that combines amoxicillin trihydrate and potassium clavulanate. The formulation pairs a beta‑lactam antibiotic with a beta‑lactamase inhibitor to broaden antibacterial coverage. It is supplied as tablets for systemic use and is classified under ATC code J01CR02. Gruzyqal is intended for the treatment of susceptible bacterial infections. It should be used only under the guidance of a qualified healthcare professional.
What is Amoxicillin Trihydrate, Potassium Clavulanate used for?
Gruzyqal is indicated for a range of common bacterial infections where amoxicillin‑clavulanate is appropriate.
- Acute bacterial sinusitis - Acute otitis media - Community‑acquired pneumonia - Uncomplicated urinary tract infections - Skin and soft‑tissue infections - Other infections caused by susceptible organisms
What are the side effects of Amoxicillin Trihydrate, Potassium Clavulanate?
Side effects reported with Gruzyqal vary from mild, self‑limiting reactions to rare but serious events.
Common: - Nausea, vomiting, or diarrhea - Abdominal pain or discomfort - Rash or mild skin irritation - Headache - Altered taste sensation - Oral thrush (candidiasis)
Serious: - Anaphylaxis or severe allergic reaction - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Clostridioides difficile‑associated colitis - Elevated liver enzymes or hepatitis - Seizures (rare) - Hemolytic anemia
What precautions apply to Amoxicillin Trihydrate, Potassium Clavulanate?
Before prescribing Gruzyqal, clinicians should evaluate several safety considerations.
- Known hypersensitivity to penicillins or beta‑lactamase inhibitors - Renal impairment may require dose adjustment - Pregnancy and lactation status should be confirmed (category unknown) - Pediatric use requires weight‑based dosing - History of gastrointestinal disease or colitis - Concomitant anticoagulant therapy may affect INR - Monitor liver function during prolonged treatment
What does Amoxicillin Trihydrate, Potassium Clavulanate interact with?
Gruzyqal can interact with other medicines, affecting efficacy or safety.
Avoid: - Methotrexate (increased toxicity) - Oral contraceptives (reduced effectiveness) - Allopurinol (higher risk of rash) - Warfarin (variable INR) - Probenecid (increased amoxicillin levels)
Use with caution: - Antacids containing aluminum or magnesium (reduce absorption) - Loop or thiazide diuretics (potential potassium loss) - Live vaccines (reduced immune response)



